DECLARATION OF CONFORMITY——XABT Supplies PCR Kit for Detection of 2019-nCoV to the EU Market
On February 27, 2020, Beijing Applied Biological Technologies Co., Ltd. and the Institute of Pathogen Biology of the Chinese Academy of Medical Sciences jointly developed 2019-nCoV nucleic acid detection kit (fluorescent PCR method) [NO.20203400179]. The reagent obtained the medical device registration certificate issued by the State Drug Administration. At present, the product has completed the European Union regional access and can be supplied to the European Union market.
FOCUS ON US
